Literature DB >> 10926831

Peroxisome-proliferator-activated receptor delta mediates the effects of long-chain fatty acids on post-confluent cell proliferation.

C Jehl-Pietri1, C Bastie, I Gillot, S Luquet, P A Grimaldi.   

Abstract

Nutritional long-chain fatty acids control adipose tissue mass by regulating the number and the size of adipocytes. It is now established that peroxisome-proliferator-activated receptors (PPARs) play crucial functions in the control of gene expression and the level of cell differentiation. PPARgamma, which is activated by specific prostanoids, is a key factor in activating terminal differentiation and adipogenesis. We have recently demonstrated that PPARdelta, once activated by fatty acids, drives the expression of a limited set of genes, including that encoding PPARgamma, thereby inducing adipose differentiation. Thus far, the mechanism of action of fatty acids in the control of preadipocyte proliferation has remained unknown. We show here that PPARdelta is directly implicated in fatty acid-induced cell proliferation. Ectopic expression of PPARdelta renders 3T3C2 cells capable of responding to treatment with long-chain fatty acids by a resumption of mitosis, and this effect is limited to a few days after confluence. This response is restricted to PPARdelta activators and, for fatty acids, takes place within the range of concentrations found to trigger differentiation of preadipocytes both in vitro and in vivo. Furthermore, the use of a mutated inactive PPARdelta demonstrated that transcriptional activity of the nuclear receptor is required to mediate fatty acid-induced proliferation. These data demonstrate that PPARdelta, as a transcription factor, is directly implicated in fatty acid-induced proliferation, and this could explain the hyperplastic development of adipose tissue that occurs in high-fat-fed animals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926831      PMCID: PMC1221229     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

Review 1.  Nuclear receptor coactivators.

Authors:  C K Glass; D W Rose; M G Rosenfeld
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

2.  The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing.

Authors:  A Baniahmad; X Leng; T P Burris; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

Review 3.  The RXR heterodimers and orphan receptors.

Authors:  D J Mangelsdorf; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

4.  15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

Authors:  B M Forman; P Tontonoz; J Chen; R P Brun; B M Spiegelman; R M Evans
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

5.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

Authors:  P Tontonoz; E Hu; R A Graves; A I Budavari; B M Spiegelman
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

6.  An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

Authors:  J M Lehmann; L B Moore; T A Smith-Oliver; W O Wilkison; T M Willson; S A Kliewer
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

7.  Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors.

Authors:  E Z Amri; F Bonino; G Ailhaud; N A Abumrad; P A Grimaldi
Journal:  J Biol Chem       Date:  1995-02-03       Impact factor: 5.157

8.  Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.

Authors:  O Braissant; F Foufelle; C Scotto; M Dauça; W Wahli
Journal:  Endocrinology       Date:  1996-01       Impact factor: 4.736

9.  Differential activation of adipogenesis by multiple PPAR isoforms.

Authors:  R P Brun; P Tontonoz; B M Forman; R Ellis; J Chen; R M Evans; B M Spiegelman
Journal:  Genes Dev       Date:  1996-04-15       Impact factor: 11.361

10.  Regulation of new fat cell formation in rats: the role of dietary fats.

Authors:  G Shillabeer; D C Lau
Journal:  J Lipid Res       Date:  1994-04       Impact factor: 5.922

View more
  12 in total

Review 1.  Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.

Authors:  Rupinder K Sodhi; Nirmal Singh; Amteshwar S Jaggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-24       Impact factor: 3.000

2.  Diminished satellite cells and elevated adipogenic gene expression in muscle as caused by ovariectomy are averted by low-magnitude mechanical signals.

Authors:  Danielle M Frechette; Divya Krishnamoorthy; Benjamin J Adler; M Ete Chan; Clinton T Rubin
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

Review 3.  Regulatory circuits controlling white versus brown adipocyte differentiation.

Authors:  Jacob B Hansen; Karsten Kristiansen
Journal:  Biochem J       Date:  2006-09-01       Impact factor: 3.857

Review 4.  Role of Peroxisome Proliferator-Activated Receptor (PPAR)δ in Embryonic Stem Cell Proliferation.

Authors:  Min Young Lee; Yu Jin Lee; Yun Hee Kim; Sang Hun Lee; Jae Hong Park; Mi Ok Kim; Han Na Suh; Jung Min Ryu; Seung Pil Yun; Min Woo Jang; Ho Jae Han
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

Review 5.  Activation of PPARδ: from computer modelling to biological effects.

Authors:  Shirin Kahremany; Ariela Livne; Arie Gruzman; Hanoch Senderowitz; Shlomo Sasson
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

6.  Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta.

Authors:  Karim Nadra; Silvia I Anghel; Elisabeth Joye; Nguan Soon Tan; Sharmila Basu-Modak; Didier Trono; Walter Wahli; Béatrice Desvergne
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 7.  Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

8.  Peroxisome proliferator-activated receptor-delta induces cell proliferation by a cyclin E1-dependent mechanism and is up-regulated in thyroid tumors.

Authors:  Lingchun Zeng; Yan Geng; Maria Tretiakova; Xuemei Yu; Peter Sicinski; Todd G Kroll
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

9.  PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation.

Authors:  Hongyan Yuan; Jin Lu; Junfeng Xiao; Geeta Upadhyay; Rachel Umans; Bhaskar Kallakury; Yuhzi Yin; Michael E Fant; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Res       Date:  2013-06-27       Impact factor: 12.701

10.  Peroxisome Proliferator-Activated Receptor beta/delta in the Brain: Facts and Hypothesis.

Authors:  M G Hall; Laure Quignodon; Béatrice Desvergne
Journal:  PPAR Res       Date:  2008-11-09       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.